Final legally binding decision of the European Commission for EU countries on determining the DPD enzyme level before starting treatment with medicinal products containing fluorouracil, capecitabine, and tegafur
20.07.2020
1909
Final decision of the European Commission, adopted in July 2020, on mandatory testing of the DPD enzyme level before treatment with products based on fluorouracil, capecitabine, and tegafur. The document contains recommendations for patients and healthcare professionals and a list of the relevant medicinal products authorized in Ukraine. compiled automatically
Read more